What over‑the‑counter medications are recommended for treating an uncomplicated viral cough, including appropriate dosing and safety considerations?

Over-the-Counter Medications for Viral Cough

For uncomplicated viral cough, start with honey and lemon as first-line therapy, then use dextromethorphan 30–60 mg every 6–8 hours (maximum 120 mg daily) if pharmacological treatment is needed; avoid codeine-containing products entirely due to lack of efficacy advantage and significantly higher adverse effects. 1

First-Line Non-Pharmacological Approach

• Honey and lemon mixture is the simplest, cheapest, and evidence-supported first-line treatment for acute viral cough, with patient-reported benefit comparable to pharmacological options. 1, 2
• Voluntary cough suppression through central modulation may be sufficient to reduce cough frequency without medication in some patients. 1
• These simple remedies work through central modulation of the cough reflex and demulcent coating of the pharyngeal mucosa. 1

Preferred Pharmacological Agent: Dextromethorphan

Dosing and Efficacy

• Dextromethorphan is the recommended first-line antitussive due to its superior safety profile compared to opioid alternatives. 1, 2
• The optimal dose for maximal cough suppression is 30–60 mg per dose (every 6–8 hours), with a maximum daily dose of 120 mg. 1, 2
• Standard over-the-counter doses (10–15 mg) are subtherapeutic and often inadequate for meaningful symptom relief. 1, 2
• Maximum cough reflex suppression occurs at 60 mg and can be prolonged at this dosage level. 1, 2
• A bedtime dose of 15–30 mg may help suppress nocturnal cough and promote undisturbed sleep. 1

Important Safety Considerations

• Exercise caution with combination preparations (e.g., products containing acetaminophen), as higher doses of dextromethorphan could lead to excessive amounts of other ingredients and risk hepatotoxicity. 1, 2
• Dextromethorphan is primarily metabolized hepatically by CYP2D6, not renally excreted, so no dose adjustment is required for patients with chronic kidney disease. 1
• Avoid concurrent use with three or more CNS-active agents (antidepressants, antipsychotics, benzodiazepines, antiepileptics, opioids) due to increased fall risk. 1

Evidence Quality and Limitations

• Evidence for dextromethorphan efficacy is mixed across different populations; it achieves less than 20% cough suppression in acute upper respiratory infections but 40–60% reduction in chronic bronchitis/COPD-related cough. 1
• The American College of Chest Physicians notes that central cough suppressants have limited efficacy for acute cough due to upper respiratory infection. 1
• Despite mixed evidence, dextromethorphan remains the preferred agent when pharmacological treatment is deemed necessary. 1, 3

Alternative Options for Specific Situations

For Nocturnal Cough

• First-generation sedating antihistamines (e.g., diphenhydramine, but NOT promethazine) may be used for nighttime cough because their sedative properties help reduce cough while promoting sleep. 1, 2
• These agents suppress cough through sedation but cause drowsiness, making them particularly suitable when cough disrupts sleep. 1

For Acute Breakthrough Symptoms

• Menthol inhalation (crystals or proprietary capsules) provides acute but short-lived cough suppression through direct suppression of the cough reflex when inhaled. 1, 2
• The effect is temporary and useful only for quick symptomatic relief. 1

Agents NOT Recommended

Codeine and Pholcodine

• Codeine-containing products should be avoided entirely because they provide no greater cough-suppression efficacy than dextromethorphan but are associated with significantly higher adverse effects. 1, 2
• Adverse effects include drowsiness, nausea, constipation, respiratory depression, and risk of physical dependence. 1, 2
• The British Thoracic Society explicitly recommends against using codeine-containing antitussives for cough management. 1, 2

Guaifenesin (Expectorants)

• Guaifenesin is NOT indicated for dry (non-productive) cough because it functions as an expectorant, not a cough suppressant. 1
• The American College of Chest Physicians assigns a Grade D recommendation (good evidence of no benefit) against mucolytic agents for cough suppression. 1
• Controlled trials demonstrate guaifenesin is ineffective for improving cough clearance in bronchitis. 1

Promethazine

• Promethazine has no established efficacy for cough suppression and is associated with serious adverse effects including hypotension, respiratory depression, neuroleptic malignant syndrome, and extrapyramidal reactions. 1
• The British Thoracic Society recommends against using promethazine for cough management. 1

Antihistamines (Newer Non-Sedating)

• Newer non-sedating antihistamines are ineffective against cough and should not be used. 3

Critical Pitfalls to Avoid

• Using subtherapeutic doses of dextromethorphan (less than 30 mg) will likely fail to provide adequate cough relief. 1, 2
• Prescribing codeine-containing products lacks efficacy advantage and increases side-effect burden. 1, 2
• Using expectorants for dry cough is inappropriate because the therapeutic goal is suppression, not secretion clearance. 1
• Suppressing productive cough in conditions like pneumonia or bronchiectasis where clearance is essential should be avoided. 1

Red Flags Requiring Medical Evaluation (Not OTC Treatment)

• Cough with increasing breathlessness should be assessed for asthma exacerbation or anaphylaxis before using antitussives. 1
• Cough with fever, malaise, or purulent sputum may indicate serious lung infection requiring antibiotics and bronchodilators, not cough suppression. 1
• Tachycardia, tachypnea, fever, or abnormal chest examination requires ruling out pneumonia first; dextromethorphan should not be used until pneumonia is excluded. 1
• Significant hemoptysis or possible foreign body inhalation requires specialist referral. 1
• Cough persisting beyond 3 weeks requires full diagnostic workup rather than continued antitussive therapy. 1, 2

Practical Treatment Algorithm

1. Start with honey and lemon mixture for all patients with uncomplicated viral cough. 1, 2
2. If additional relief is needed, prescribe dextromethorphan 30–60 mg every 6–8 hours (maximum 120 mg daily), ensuring the product does not contain excessive acetaminophen or other ingredients. 1, 2
3. For nocturnal cough disrupting sleep, consider adding a first-generation sedating antihistamine at bedtime (NOT promethazine). 1, 2
4. For quick temporary relief, menthol inhalation may be used as needed. 1, 2
5. Reassess after 1–3 weeks; if cough persists beyond 3 weeks, discontinue antitussive therapy and investigate alternative diagnoses. 1, 2